Using paper chart based clinical reminders to improve guideline adherence to lipid management

Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods  Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible...

Full description

Saved in:
Bibliographic Details
Published inJournal of evaluation in clinical practice Vol. 14; no. 5; pp. 861 - 866
Main Authors Hung, Chi-Sheng, Lin, Jou-Wei, Hwang, Juey-Jen, Tsai, Ru-Yi, Li, Ai-Tzu
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.10.2008
Subjects
Online AccessGet full text
ISSN1356-1294
1365-2753
1365-2753
DOI10.1111/j.1365-2753.2008.01066.x

Cover

Loading…
Abstract Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods  Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up. Results  Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57–5.04). Conclusion  A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint.
AbstractList The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines. Patients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up. Ninety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04). A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint.
The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.RATIONALE, AIMS AND OBJECTIVESThe objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.Patients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up.METHODSPatients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up.Ninety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04).RESULTSNinety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04).A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint.CONCLUSIONA paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint.
Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods  Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up. Results  Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57–5.04). Conclusion  A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint.
Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods  Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up. Results  Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P  = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P  = 0.001, 95% CI: 1.57–5.04). Conclusion  A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint.
Author Li, Ai-Tzu
Hung, Chi-Sheng
Lin, Jou-Wei
Hwang, Juey-Jen
Tsai, Ru-Yi
Author_xml – sequence: 1
  givenname: Chi-Sheng
  surname: Hung
  fullname: Hung, Chi-Sheng
  organization: Attending cardiologist
– sequence: 2
  givenname: Jou-Wei
  surname: Lin
  fullname: Lin, Jou-Wei
  organization: Attending cardiologist
– sequence: 3
  givenname: Juey-Jen
  surname: Hwang
  fullname: Hwang, Juey-Jen
  organization: Professor
– sequence: 4
  givenname: Ru-Yi
  surname: Tsai
  fullname: Tsai, Ru-Yi
  organization: Registered nurse, Cardiovascular Center, National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin, Taiwan
– sequence: 5
  givenname: Ai-Tzu
  surname: Li
  fullname: Li, Ai-Tzu
  email: irisli@ccu.edu.tw
  organization: Assistant Professor, Department and Institute of Adult and Continuing Education, National Chung-Cheng University, Min-Hsiung, Chia-Yi, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19018919$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtv1DAUhS1URB_wF5BX7BLsiZ8LkFBVCqiCWRRmhSzHvjP1kDjBzsD03-MwZRZswBtf6Z7v-vqcc3QShwgIYUpqWs7LbU0bwauF5E29IETVhBIh6v0jdHZsnMw1FxVdaHaKznPeEkIbwuUTdEo1oUpTfYa-fs4hbvBoR0jY3dk04dZm8Nh1IQZnO5ygD9FDyngacOjHNPwAvNkFD0UB2Po7SBAdzO0ujMHj3ka7gR7i9BQ9Xtsuw7OH-wLdvr26vXxX3Xy6fn_55qZyTFJROem0VLRRzjEAJ6zgLTDNy5a8ZZqpxnnfMrJuuZOKMSssAetbqYSzmjYX6MVhbFnu-w7yZPqQHXSdjTDsshFaUc4WpAifPwh3bQ_ejCn0Nt2bP34UweuDwKUh5wRr48JkpzDEKdnQGUrMHIDZmtlnM_ts5gDM7wDMvgxQfw04vvFv9NUB_Rk6uP9vzny4Ws5V4asDH_IE-yNv0zcjZCO5WX28Lj9dyZX8sjTL5hduCa0Y
CitedBy_id crossref_primary_10_1136_bmjopen_2017_018271
crossref_primary_10_1093_fampra_cmt080
crossref_primary_10_1097_NNA_0b013e31824ccd0a
crossref_primary_10_1371_journal_pone_0110619
crossref_primary_10_1186_s13012_021_01108_0
crossref_primary_10_1002_14651858_CD001174_pub4
crossref_primary_10_2196_60326
crossref_primary_10_1253_circrep_CR_21_0165
crossref_primary_10_1111_j_1365_2753_2008_01094_x
Cites_doi 10.1056/NEJM199511163332001
10.1016/j.amjcard.2004.11.051
10.1016/S0140-6736(03)13636-7
10.1111/j.1525-1497.2005.00268.x
10.1161/01.CIR.0000020190.45892.75
10.1161/01.CIR.0000070952.08969.5B
10.1136/bmj.38398.500764.8F
10.7326/0003-4819-136-8-200204160-00005
10.2165/00044011-200727090-00006
10.1111/j.1532-5415.1999.tb07233.x
10.1592/phco.21.9.818.34563
10.1016/j.ijcard.2003.11.002
ContentType Journal Article
Copyright 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd
Copyright_xml – notice: 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1365-2753.2008.01066.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2753
EndPage 866
ExternalDocumentID 19018919
10_1111_j_1365_2753_2008_01066_x
JEP1066
ark_67375_WNG_19W7W7VP_P
Genre article
Randomized Controlled Trial
Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EAD
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c4716-c7c978138cc4eec6a65be4959015b49483cddb40fb5c7844a6a0eadb786ca913
IEDL.DBID DR2
ISSN 1356-1294
1365-2753
IngestDate Fri Jul 11 05:26:42 EDT 2025
Thu May 22 04:42:31 EDT 2025
Thu Apr 24 22:51:54 EDT 2025
Tue Jul 01 04:01:54 EDT 2025
Wed Jan 22 16:27:24 EST 2025
Wed Oct 30 09:57:10 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4716-c7c978138cc4eec6a65be4959015b49483cddb40fb5c7844a6a0eadb786ca913
Notes ark:/67375/WNG-19W7W7VP-P
ArticleID:JEP1066
istex:3417B1E6BCF294C834D89219B1CE724ED238979F
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 19018919
PQID 69815420
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_69815420
pubmed_primary_19018919
crossref_citationtrail_10_1111_j_1365_2753_2008_01066_x
crossref_primary_10_1111_j_1365_2753_2008_01066_x
wiley_primary_10_1111_j_1365_2753_2008_01066_x_JEP1066
istex_primary_ark_67375_WNG_19W7W7VP_P
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-10
October 2008
2008-10-00
2008-Oct
20081001
PublicationDateYYYYMMDD 2008-10-01
PublicationDate_xml – month: 10
  year: 2008
  text: 2008-10
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle Journal of evaluation in clinical practice
PublicationTitleAlternate J Eval Clin Pract
PublicationYear 2008
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Nakagawa, T. , Kobayashi, T. , Awata, N. , et al. (2004) Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study. International Journal of Cardiology, 97 (1), 107-114.
Lester, W. T. , Grant, R. W. , Barnett, G. O. & Chueh, H. C. (2006) Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. Journal of General Internal Medicine, 21 (1), 22-29.
Nag, S. S. , Pearson, T. A. , Ma, L. , Landsman, P. B. , Cimino, A. , Vickers, F. F. , Alexander, C. M. & Melin, J. M. (2005) Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. The American Journal of Cardiology, 95 (7), 862-864.
Straka, R. J. , Taheri, R. , Cooper, S. L. , Tan, A. W. & Smith, A. C. (2001) Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy, 21 (7), 818-827.
Saaddine, J. B. , Engelgau, M. M. , Beckles, G. L. , Gregg, E. W. , Thompson, T. J. & Narayan, K. M. (2002) A diabetes report card for the United States: quality of care in the 1990s. Annals of Internal Medicine, 136 (8), 565-574.
Pearson, T. A. , Blair, S. N. , Daniels, S. R. , et al. (2002) Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106 (3), 388-391.
Kawamoto, K. , Houlihan, C. A. , Balas, E. A. & Lobach, D. F. (2005) Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ, 330 (7494), 765.
Kell, S. H. , Drass, J. , Bausell, R. B. , Thomas, K. A. , Osborn, M. A. & Gohdes, D. (1999) Measures of disease control in Medicare beneficiaries with diabetes mellitus. Journal of the American Geriatrics Society, 47 (4), 417-422.
Scandinavian Simvastatin Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 (8934), 1383-1389.
Ansari, M. , Shlipak, M. G. , Heidenreich, P. A. , Van Ostaeyen, D. , Pohl, E. C. , Browner, W. S. & Massie, B. M. (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation, 107 (22), 2799-2804.
Paragh, G. , Márk, L. , Zámolyi, K. , Pados, G. & Ofner, P. (2007) Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study. Clinical Drug Investigation, 27 (9), 647-660.
Collins, R. , Armitage, J. , Parish, S. , Sleigh, P. , Peto, R. & Heart Protection Study Collaborative G.roup (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361 (9374), 2005-2016.
Shepherd, J. , Cobbe, S. M. , Ford, I. , Isles, C. G. , Lorimer, A. R. , MacFarlane, P. W. , McKillop, J. H. & Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine, 333 (20), 1301-1307.
1994; 344
2004; 97
2003; 107
2005; 330
2006; 21
2002; 136
1999; 47
2002; 106
2005; 95
1995; 333
2003; 361
2001; 21
2007; 27
Scandinavian Simvastatin Study (4S) (e_1_2_6_4_2) 1994; 344
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_12_2
e_1_2_6_13_2
e_1_2_6_2_2
e_1_2_6_10_2
e_1_2_6_11_2
e_1_2_6_14_2
References_xml – reference: Paragh, G. , Márk, L. , Zámolyi, K. , Pados, G. & Ofner, P. (2007) Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study. Clinical Drug Investigation, 27 (9), 647-660.
– reference: Collins, R. , Armitage, J. , Parish, S. , Sleigh, P. , Peto, R. & Heart Protection Study Collaborative G.roup (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361 (9374), 2005-2016.
– reference: Ansari, M. , Shlipak, M. G. , Heidenreich, P. A. , Van Ostaeyen, D. , Pohl, E. C. , Browner, W. S. & Massie, B. M. (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation, 107 (22), 2799-2804.
– reference: Shepherd, J. , Cobbe, S. M. , Ford, I. , Isles, C. G. , Lorimer, A. R. , MacFarlane, P. W. , McKillop, J. H. & Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine, 333 (20), 1301-1307.
– reference: Straka, R. J. , Taheri, R. , Cooper, S. L. , Tan, A. W. & Smith, A. C. (2001) Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy, 21 (7), 818-827.
– reference: Lester, W. T. , Grant, R. W. , Barnett, G. O. & Chueh, H. C. (2006) Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. Journal of General Internal Medicine, 21 (1), 22-29.
– reference: Pearson, T. A. , Blair, S. N. , Daniels, S. R. , et al. (2002) Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106 (3), 388-391.
– reference: Kawamoto, K. , Houlihan, C. A. , Balas, E. A. & Lobach, D. F. (2005) Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ, 330 (7494), 765.
– reference: Saaddine, J. B. , Engelgau, M. M. , Beckles, G. L. , Gregg, E. W. , Thompson, T. J. & Narayan, K. M. (2002) A diabetes report card for the United States: quality of care in the 1990s. Annals of Internal Medicine, 136 (8), 565-574.
– reference: Kell, S. H. , Drass, J. , Bausell, R. B. , Thomas, K. A. , Osborn, M. A. & Gohdes, D. (1999) Measures of disease control in Medicare beneficiaries with diabetes mellitus. Journal of the American Geriatrics Society, 47 (4), 417-422.
– reference: Nakagawa, T. , Kobayashi, T. , Awata, N. , et al. (2004) Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study. International Journal of Cardiology, 97 (1), 107-114.
– reference: Scandinavian Simvastatin Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 (8934), 1383-1389.
– reference: Nag, S. S. , Pearson, T. A. , Ma, L. , Landsman, P. B. , Cimino, A. , Vickers, F. F. , Alexander, C. M. & Melin, J. M. (2005) Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. The American Journal of Cardiology, 95 (7), 862-864.
– volume: 136
  start-page: 565
  issue: 8
  year: 2002
  end-page: 574
  article-title: A diabetes report card for the United States: quality of care in the 1990s
  publication-title: Annals of Internal Medicine
– volume: 97
  start-page: 107
  issue: 1
  year: 2004
  end-page: 114
  article-title: Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5‐year angiographic follow‐up of the Prevention of Coronary Sclerosis (PCS) study
  publication-title: International Journal of Cardiology
– volume: 344
  start-page: 1383
  issue: 8934
  year: 1994
  end-page: 1389
  article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  publication-title: Lancet
– volume: 106
  start-page: 388
  issue: 3
  year: 2002
  end-page: 391
  article-title: Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
  publication-title: Circulation
– volume: 330
  start-page: 765
  issue: 7494
  year: 2005
  article-title: Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
  publication-title: BMJ
– volume: 95
  start-page: 862
  issue: 7
  year: 2005
  end-page: 864
  article-title: Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
  publication-title: The American Journal of Cardiology
– volume: 21
  start-page: 22
  issue: 1
  year: 2006
  end-page: 29
  article-title: Randomized controlled trial of an informatics‐based intervention to increase statin prescription for secondary prevention of coronary disease
  publication-title: Journal of General Internal Medicine
– volume: 27
  start-page: 647
  issue: 9
  year: 2007
  end-page: 660
  article-title: Lipid‐modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study
  publication-title: Clinical Drug Investigation
– volume: 21
  start-page: 818
  issue: 7
  year: 2001
  end-page: 827
  article-title: Assessment of hypercholesterolemia control in a managed care organization
  publication-title: Pharmacotherapy
– volume: 333
  start-page: 1301
  issue: 20
  year: 1995
  end-page: 1307
  article-title: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
  publication-title: The New England Journal of Medicine
– volume: 47
  start-page: 417
  issue: 4
  year: 1999
  end-page: 422
  article-title: Measures of disease control in Medicare beneficiaries with diabetes mellitus
  publication-title: Journal of the American Geriatrics Society
– volume: 361
  start-page: 2005
  issue: 9374
  year: 2003
  end-page: 2016
  article-title: MRC/BHF Heart Protection Study of cholesterol‐lowering with simvastatin in 5963 people with diabetes: a randomised placebo‐controlled trial
  publication-title: Lancet
– volume: 107
  start-page: 2799
  issue: 22
  year: 2003
  end-page: 2804
  article-title: Improving guideline adherence: a randomized trial evaluating strategies to increase beta‐blocker use in heart failure
  publication-title: Circulation
– ident: e_1_2_6_3_2
  doi: 10.1056/NEJM199511163332001
– ident: e_1_2_6_9_2
  doi: 10.1016/j.amjcard.2004.11.051
– ident: e_1_2_6_2_2
  doi: 10.1016/S0140-6736(03)13636-7
– volume: 344
  start-page: 1383
  issue: 8934
  year: 1994
  ident: e_1_2_6_4_2
  article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  publication-title: Lancet
– ident: e_1_2_6_11_2
  doi: 10.1111/j.1525-1497.2005.00268.x
– ident: e_1_2_6_5_2
  doi: 10.1161/01.CIR.0000020190.45892.75
– ident: e_1_2_6_14_2
  doi: 10.1161/01.CIR.0000070952.08969.5B
– ident: e_1_2_6_13_2
  doi: 10.1136/bmj.38398.500764.8F
– ident: e_1_2_6_7_2
  doi: 10.7326/0003-4819-136-8-200204160-00005
– ident: e_1_2_6_10_2
  doi: 10.2165/00044011-200727090-00006
– ident: e_1_2_6_6_2
  doi: 10.1111/j.1532-5415.1999.tb07233.x
– ident: e_1_2_6_8_2
  doi: 10.1592/phco.21.9.818.34563
– ident: e_1_2_6_12_2
  doi: 10.1016/j.ijcard.2003.11.002
SSID ssj0013057
Score 1.8620714
Snippet Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods ...
Rationale, aims and objectives  The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods ...
The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines. Patients with coronary heart disease...
The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.RATIONALE, AIMS AND OBJECTIVESThe...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 861
SubjectTerms Aged
Attitude of Health Personnel
behaviour and behaviour mechanisms
Chi-Square Distribution
Coronary Disease - diagnosis
Coronary Disease - etiology
Coronary Disease - prevention & control
Decision Support Systems, Clinical
Drug Prescriptions - statistics & numerical data
Female
Follow-Up Studies
guideline
Guideline Adherence - organization & administration
Health Knowledge, Attitudes, Practice
HMG-CoA
Humans
Hyperlipidemias - prevention & control
Hypolipidemic Agents - therapeutic use
Logistic Models
Male
Medical Records
Practice Guidelines as Topic
Practice Patterns, Physicians' - organization & administration
Reimbursement, Incentive
reminder systems
Reminder Systems - instrumentation
statins
Taiwan
Title Using paper chart based clinical reminders to improve guideline adherence to lipid management
URI https://api.istex.fr/ark:/67375/WNG-19W7W7VP-P/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2753.2008.01066.x
https://www.ncbi.nlm.nih.gov/pubmed/19018919
https://www.proquest.com/docview/69815420
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEB5EQbz4fqzPHMRbyz6z2WN9VBGUImq9SEiyiZZqW-oWir_ezD6qFQ8i3hbCZDeTmZ2ZZOYbgENqqPS1VUBpXIMtzLAboDE1YTecWfMhfIW1w1fX9OIuvHyIHsr8J6yFKfAhJgduqBn5_xoVXMi3aSUv6qmioEyJtNENraM_iQPoH934nxcKbg766QUIu-cn4XRSz48TTVmqOWT6-Cc3dNqrzc1Scwm61YKKbJRufZTJunr_hvX4PytehsXSeyWNQtxWYEb3VmH-qryfX4PHPAOBDMRADwkWdGUEzWRKqgJMMkQwE0yeJlmfdPITDU2eRgi2ZWcgIn0u6g9x-KUz6KTkdZKgsw63zbPbk4ta2cChpqzNozUVK4TUCphSodaKChpJbSMy9EEk4tIEKk1l6BoZqZiFoaDCtZItY0aVSLxgA2Z7_Z7esnvFvFCIRIogsQG9EswwXxrNolAzE6TMgbjaK65KcHPssfHCvwQ5lnkcmVe23kTm8bED3oRyUAB8_ILmKBeHCYEYdjFBLo54-_qce0k7bsf3Ld5y4KCSF27VFu9iRE_3R2-cJsw6r77rwGYhRp8vt9xhiZc4QHNh-PVX8cuzFj5t_5VwBxb8Cu3X24XZbDjSe9blyuQ-zDWOT4-b-7lSfQB3MhyJ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9owEB5VILV76faxu832gQ9Vb6A8HedYtVBKAaGKFi4ry3bsFsECYoOE-uvryYMtFQdU9RYpGicZz2TG9sz3AbylhkpfWweUxjVIYYZsgMY0hZ1wZsOH8BX2Dg-GtPst7E2jaUkHhL0wBT7EfsMNPSP_X6OD44b0oZcXDVVRUNZE2uUNbdmEso4E30hn8PGrf3-k4Oawn16AwHt-Eh6W9Rwd6SBW1VHtu2OJ6GFemwemzjksqk8q6lHmrW0mW-rXX2iP_-mbn8DjMoEl7wuLewoP9PIZPByUR_TP4SYvQiBrsdYbgj1dGcFImZKqB5NsEM8E66dJtiKzfFNDkx9bxNuyIxCR_ixaEPH2YraepeR2X6NzAeNOe_yh2yw5HJrKhj3aVLFCVK2AKRVqraigkdR2UYZpiERomkClqQxdIyMVszAUVLjWuGXMqBKJF1xCbbla6hd2spgXCpFIESR2Ta8EM8yXRrMo1MwEKXMgriaLqxLfHGk2FvyPdY5VHkflleybqDy-c8DbS64LjI8TZN7l9rAXEJs51sjFEZ8MP3EvmcST-PuIjxxoVAbDreficYxY6tX2jtOE2fzVdx24Kuzo_uFWOyzxEgdobg0nvxXvtUd4df2vgg141B0P-rz_efjlJZz5Ffiv9wpq2WarX9sMLJNvcs_6DU-uHzE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9swDCaGFih22avr6u5RHYrdEvghy_Jx2Jp13RoEQ7f0UgiSLHVB0sTIHKDYrx_pR7oMPRTDbgYMyjZFmpT08SPAkfDCxA4d0PjQUwsz6gbofU_jhEsMHzq2VDt8NhQn3_jpRXrR4p-oFqbhh1hvuJFn1P9rcvCy8JtO3tRTpUkLicTVjehjPrnNBfoOJUhf49sThbBm_YwS4t2Lc76J6rlzpI1QtU1av7krD91Ma-u4NHgM0-6LGjjKtL-qTN_--ovs8f988hN41Kav7F1jb0_hgZs_g52z9oB-Fy5rCAIrdemWjCq6KkZxsmBdBSZbEpsJoadZtWCTekvDsasVsW3hCEwXP5oCRLo9m5STgl2vETrP4XxwfP7-pNd2cOhZDHqiZzNLnFqJtJY7Z4UWqXG4JKMkxBAxTWKLwvDQm9RmknMtdIimbTIprM6jZA-25ou528e5khHXOjc6yXFFb7X0MjbeyZQ76ZNCBpB1c6Vsy25OTTZm6o9VDipPkfLa3pukPHUTQLSWLBuGj3vIvK3NYS2gl1NCyGWpGg8_qigfZ-Ps-0iNAjjs7EWh39JhjJ67xeqnErnE7DUOA3jRmNHtw1E7Mo_yAERtDPd-K3V6PKKrg38VPISd0YeB-vJp-PklPIw75t_oFWxVy5V7jelXZd7UfvUb4oQd6Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+paper+chart+based+clinical+reminders+to+improve+guideline+adherence+to+lipid+management&rft.jtitle=Journal+of+evaluation+in+clinical+practice&rft.au=Hung%2C+Chi-Sheng&rft.au=Lin%2C+Jou-Wei&rft.au=Hwang%2C+Juey-Jen&rft.au=Tsai%2C+Ru-Yi&rft.date=2008-10-01&rft.eissn=1365-2753&rft.volume=14&rft.issue=5&rft.spage=861&rft_id=info:doi/10.1111%2Fj.1365-2753.2008.01066.x&rft_id=info%3Apmid%2F19018919&rft.externalDocID=19018919
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1356-1294&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1356-1294&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1356-1294&client=summon